Aspira Women's Health Secures Laboratory Services Agreement with University of Texas Medical Branch
Aspira Women’s Health Inc. has entered into a 12-month laboratory services agreement with the University of Texas Medical Branch at Galveston. This partnership aims to enhance the distribution of Aspira’s Ova1Plus® and OvaWatch® products, expanding their reach to a larger patient base in Texas.
Aspira Women’s Health Inc. has announced the execution of a new laboratory services agreement with the University of Texas Medical Branch at Galveston (UTMB Galveston), part of the University of Texas System. The initial term of the agreement is 12 months. This partnership is part of Aspira’s strategy to expand the reach of its Ova1Plus® and OvaWatch® products to larger organizations, enabling access to a broader patient base in the Texas market. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspira Women’s Health Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1092971) on October 29, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)
